HOB Biotech Group Corp Ltd (688656) — Financial Flexibility Index
HOB Biotech Group Corp Ltd (688656) has a Financial Flexibility Index of 0.21x as of December 2025. Free cash flow of CN¥23.78 Million (operating CF CN¥15.28 Million minus capex CN¥8.50 Million) represents 0% of total liabilities (CN¥111.30 Million). Check HOB Biotech Group Corp Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
HOB Biotech Group Corp Ltd Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for HOB Biotech Group Corp Ltd across 10 annual periods. For the full cash flow conversion analysis, see 688656 cash flow conversion.
Annual Financial Flexibility Index for HOB Biotech Group Corp Ltd (2016–2025)
Year-by-year free cash flow to debt coverage for HOB Biotech Group Corp Ltd. Explore 688656 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.32x | CN¥146.85 Million | CN¥72.94 Million | CN¥111.30 Million | ▲ +13.5% |
| 2024 | 1.16x | CN¥256.59 Million | CN¥101.22 Million | CN¥220.67 Million | ▼ -42.6% |
| 2023 | 2.03x | CN¥280.72 Million | CN¥102.69 Million | CN¥138.52 Million | ▲ +20.0% |
| 2022 | 1.69x | CN¥278.51 Million | CN¥58.31 Million | CN¥164.99 Million | ▼ -41.9% |
| 2021 | 2.90x | CN¥272.68 Million | CN¥104.79 Million | CN¥93.92 Million | ▲ +126.8% |
| 2020 | 1.28x | CN¥115.24 Million | CN¥58.22 Million | CN¥90.02 Million | ▲ +65.4% |
| 2019 | 0.77x | CN¥103.37 Million | CN¥68.57 Million | CN¥133.54 Million | ▼ -2.6% |
| 2018 | 0.79x | CN¥73.17 Million | CN¥46.51 Million | CN¥92.10 Million | ▲ +20.2% |
| 2017 | 0.66x | CN¥43.08 Million | CN¥22.26 Million | CN¥65.20 Million | ▲ +90.4% |
| 2016 | 0.35x | CN¥23.58 Million | CN¥6.42 Million | CN¥67.94 Million | — |